Date/Times: Wednesday, June 17, 2020 at 5 PM PST and 8 PM PST

In this LIVE BROADCAST Dr. Hope S. Rugo will:

the clinical landscape of metastatic triple-negative breast cancer (TNBC)

appropriate populations for a new metastatic TNBC therapy

recent data demonstrating the clinical efficacy and safety of a new therapy in patients with metastatic TNBC

Professor of Medicine; Director, Breast Oncology & Clinical Trials Education, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California

News

® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses. 

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Join us for a live broadcast on Wednesday, June 17, 2020 at 5 PM PST and 8 PM PST.

Live Broadcast on Metastatic Triple-Negative Breast Cancer